1 In addition, we have identified a second resistance-associate
2 In addition, we have identified a tension-sensitive upstream
3 In addition, we have identified an off-cycle pathway involvin
4 In addition, we have identified novel tumor-derived factors,
5 In addition, we have identified three class I alpha-mannosida
6 In all, we have identified Pik3c2b as a genetic modifier of M
7 In conclusion, we have identified a molecular signature induc
8 In conclusion, we have identified a new cellular pathway in w
9 In conclusion, we have identified a novel LKB1 isoform that e
10 In conclusion, we have identified a novel mechanism for C9ALS
11 In conclusion, we have identified a novel S. pyogenes enzyme
12 In conclusion, we have identified a PI3K/PKCiota/cyclin E sig
13 In conclusion, we have identified a putative functional indel
14 In conclusion, we have identified a robust alcohol-related DN
15 In conclusion, we have identified a statistically significant
16 In conclusion, we have identified a unique VDR agonist compou
17 In conclusion, we have identified an amphipathic alpha-helix
18 In conclusion, we have identified an inhibitor of ACSLs as a
19 In conclusion, we have identified both common and specific re
20 In conclusion, we have identified HIF-1alpha as a novel regul
21 In conclusion, we have identified miR-23a as a negative regul
22 In conclusion, we have identified new signaling molecules tha
23 In conclusion, we have identified six CPPs from large clostri
24 In conclusion, we have identified SPIN.DOC as a transcription
25 In conclusion, we have identified TMEM199 as a protein involv
26 In conclusion, we have identified urinary miR-21 that correla
27 In fact, we have identified a retrotransposon that is highly
28 Utilizing optogenetic approaches
in rats, we have identified a novel role for the anteroventra
29 In sum, we have identified a crucial role for PLIN2 in modula
30 In sum, we have identified a novel ATM subset in type 2 diabe
31 In sum, we have identified multiple biological features that
32 In sum, we have identified subpopulations of astrocytes in th
33 In summary, we have identified a BECN1 helical region that tr
34 In summary, we have identified a novel and constitutively act
35 In summary, we have identified a novel mechanism of ErbB2-med
36 In summary, we have identified a novel mechanism of P-Rex1 re
37 In summary, we have identified a novel mechanism of PLN-induc
38 In summary, we have identified a novel mechanism through whic
39 In summary, we have identified a novel role for Nod2 in obesi
40 In summary, we have identified a unique substrate-binding mot
41 In summary, we have identified ADDA 5 as a lead CcO inhibitor
42 In summary, we have identified CCL2 as a novel KIT D816V-depe
43 In summary, we have identified five candidate prenyltransfera
44 In summary, we have identified for the first time two E3 liga
45 In summary, we have identified mutations in CEP83, another DA
46 In summary, we have identified mutations in DONSON as a commo
47 In summary, we have identified novel CL/P risk loci and sugge
48 In summary, we have identified several novel genes influencin
49 In summary, we have identified several previously unrecognize
50 In summary, we have identified SGPL1 mutations in humans that